It is currently Wed Nov 26, 2014 12:06 am
New MS treatment goes on trial
A common antibiotic is the latest hope for treating multiple sclerosis (MS), which affects 85,000 people in the UK. Researchers believe minocycline could be used to supress the inflammation that destroys the protective covering of nerve fibres (myelin) in MS sufferers, causing numbness and paralysis. Animal tests suggest that minocycline could suppress MS if given in the early stages. ...
The thought is it takes not only growth factors and neurotrophins, but ALSO an elevation in cAMP at the same time in order for CNS regeneration to result.
I propose to go one step farther (based on prior research of mine). If you can also block PKC activity, inhibit Nogo-A/NgR (which is a protein that has been found to ...
Total posts 221759 • Total topics 23025 • Total members 14551